RC
RadCall Procedure Guide
← Procedure Library
Procedure Playbook

Percutaneous Spine Ablation

CT/fluoroscopy-guided thermal ablation (microwave, RFA, or cryoablation) of painful vertebral metastases or primary bone tumors — performed alone or in combination with vertebral augmentation (ablation + cement) for pain palliation and local tumor control.

Sedation
General / MAC
Bleeding Risk
Low-Mod (SIR Cat 2)
Key Risk
Cord/nerve thermal injury · Pathologic fracture
Antibiotics
Cefazolin 1g IV (if augmentation)
Follow-up
Pain 24–72h · Neuro checks q4h × 24h · MRI 6–8 wks
1

Indications & Patient Selection

Metastasis, myeloma, osteoid osteoma, patient eligibility criteria

Indications

  • Lytic vertebral metastasis with pain — standard indication; VAS >4 despite opioids; primary tumors include RCC, breast, lung, thyroid
  • Sclerotic vertebral metastasis — prostate, breast; RFA preferred (lytic lesions have lower impedance; sclerotic lesions respond to RFA through mechanical stabilization + ablation)
  • Multiple myeloma with vertebral body compression fracture — bipolar RFA + kyphoplasty; RFA creates cavity effect for more predictable cement fill
  • Spinal hemangioma — painful or aggressive; cementoplasty ± ablation
  • Osteoid osteoma of spine — RFA curative (CT-guided thermal ablation of nidus); pedicle/posterior element location
  • Radiation-resistant tumors (RCC, sarcoma) or radiation-naive patients refusing EBRT
  • Post-SBRT local progression (with radiation oncology confirmation of max dose reached)

Contraindications

  • Epidural tumor causing cord compression — surgical decompression first; ablation alone will not relieve osseous retropulsion
  • >50% vertebral body collapse without augmentation plan (fracture risk post-ablation)
  • SINS ≥13 (frank instability) — surgical stabilization required
  • Posterior wall not intact with epidural tumor <5 mm from cord without thermal protection plan
  • Cervical spine sclerotic lesions (avoid without credentialed spine surgeon backup)
  • Active infection at proposed access site
  • Life expectancy <3 months (relative; discuss with palliative care)

Patient Selection Criteria

  • ECOG performance status 0–2 (Karnofsky ≥60); ECOG 3–4 requires careful multidisciplinary discussion
  • Life expectancy ≥3 months for curative-intent procedures; palliative ablation can be considered for shorter survival if quality of life improvement expected
  • Pain VAS ≥4 despite opioid analgesia; pain localized to treated level(s)
  • ≤3 spinal levels per session (avoid excessive ablation zone in single anesthesia)
  • SINS 0–6 (stable): ablation alone or with augmentation; SINS 7–12 (potentially unstable): multidisciplinary discussion, augmentation planned; SINS ≥13: surgical consult required
  • Multidisciplinary tumor board for primary bone tumors and complex cases
2

Pre-Procedure Planning

Imaging, labs, modality selection, SBRT coordination

Imaging Review

  • Dedicated MRI spine with gadolinium — assess marrow replacement extent, epidural involvement, posterior wall integrity, cord distance
  • CT for cortical integrity, pedicle width, posterior wall assessment, and transpedicular access planning; measure distance from probe to epidural space
  • Bone scan (Tc-99m MDP) for tumor burden and additional sites not seen on MRI
  • PET-CT for treatment response planning (metabolically active disease)
  • Confirm: lesion is lytic vs. sclerotic vs. mixed (determines ablation modality preference)
  • Confirm posterior vertebral wall intact; <5 mm epidural clearance = thermal protection required

Labs & Multidisciplinary

  • CBC, CMP, coagulation; type and screen for augmentation cases
  • Neurologic exam baseline: document motor strength, reflexes, sensory level
  • Multidisciplinary tumor board for primary bone tumors (osteoid osteoma diagnosis required before RFA)
  • Radiation oncology coordination: SBRT vs. ablation discussion; if prior SBRT → confirm max cord dose not exceeded; document radiation-induced fracture risk
  • Spine surgery consultation if SINS ≥7 (potential instability)
  • Anesthesia plan: general vs. MAC; motor/sensory evoked potential monitoring for complex cases near cord

Ablation Modality Selection

ModalityBest ForAdvantageLimitation
RFA (navigational bipolar)Lytic & sclerotic mets; osteoid osteoma; myelomaReal-time thermocouple monitoring; no grounding pads; articulating electrode reaches central VB; creates cavity for cementAblation zone occult on CT; heat-sink from CSF/venous plexus
MWALarger lytic mets; osteoblastic lesions; near vasculatureLess heat-sink; works in sclerotic bone; no grounding pads; faster large zoneZone less predictable; rapid high power → neural injury risk; tip artifact on CT
CryoablationLarge soft tissue component; posterior elements; paravertebral extension; MRI-compatible casesIce ball visible in real time on CT; less intraprocedural pain; multiple probes for sculpted zoneNo visualization in osteoblastic lesions; longer procedure; delay cement by 30–60 min post-thaw
MRI spine reviewed. Posterior wall integrity confirmed. Epidural clearance measured.
SINS score calculated. Surgical consultation obtained if SINS ≥7.
Modality selected and probe/equipment confirmed available. Verify manufacturer protocol for target lesion diameter.
Thermal protection strategy planned if posterior wall compromised or epidural clearance <1 cm (cold saline, CO2, thermocouple monitoring).
Augmentation plan confirmed (cement type, approach) if fracture risk or fracture present.
Neurosurgery/spine surgery notified as backup for complex cases near cord.
3

Anatomy & Safety Considerations

Critical zones, posterior wall, thermal protection techniques

Critical Anatomic Zones

  • Posterior vertebral body wall — most critical boundary; intact cortex does NOT prevent thermal energy propagation (all modalities)
  • Epidural space — target safety margin: ≥1 cm from spinal cord; 5–10 mm = thermal protection required; <5 mm = high risk, reconsider approach
  • Pedicles — transpedicular access; avoid medial wall breach → epidural space; pedicle width determines cannula size
  • Neuroforamina — exiting nerve roots at each level; foraminal thermal spread causes radiculopathy
  • Heat-sink effect: posterior vertebral body and pedicles benefit from CSF/venous plexus cooling — limits posterior cord injury but also limits ablation efficacy posteriorly

Thermal Protection Techniques

  • Epidural cold saline hydrodissection: epidural catheter → cold D5W (ionic solutions conduct electricity, avoid with RFA) → active cooling during ablation; initiate when epidural temperature reaches 45°C (heat) or 10°C (cryo)
  • CO2 pneumodissection: inject CO2 into epidural space or neuroforamina → insulating gas layer prevents thermal conduction to cord; monitor volume to avoid cord compression
  • Thermocouple monitoring: temperature probes in epidural space and/or foramina → real-time feedback; pause ablation if temp exceeds 45°C (heat) or falls below 10°C (cryo)
  • Neurophysiology monitoring: motor/somatosensory evoked potentials (MEPs/SSEPs) for cord-adjacent procedures; changes = stop ablation
  • Patient feedback (moderate sedation): maintain consciousness during ablation to detect radiculopathy; patient reports = stop and assess
4

Technique

Ablation + vertebral augmentation combined approach
Supplies
11G or 13G bone access cannula (transpedicular) Navigational bipolar RFA electrodes (OsteoCool / STAR) MWA antenna 13–17G (if MWA planned) 17G cryoprobes + console (if cryo planned) PMMA bone cement + delivery system Balloon kyphoplasty set (if height restoration desired) Epidural catheter + cold D5W (thermal protection) CO2 insufflator + needle (pneumodissection) Thermocouples for epidural monitoring C-arm fluoroscopy or CT fluoroscopy suite Dexamethasone 10 mg IV + ketorolac 15–30 mg IV Cefazolin 1g IV (if augmentation)

Ablation + Augmentation Combined Technique

1

Positioning, Anesthesia & Setup

Prone positioning on radiolucent table. General anesthesia preferred (controlled ventilation, stable platform); MAC acceptable for moderate sedation cases where patient feedback is desired during ablation. Maintain consciousness during ablation with MAC for early neural injury detection. Bilateral grounding pads (monopolar RFA only). IV access ×2.
2

Pre-Procedure Medications

Dexamethasone 10 mg IV (reduces post-ablation edema) + ketorolac 15–30 mg IV (reduces immediate post-ablation pain). Cefazolin 1g IV 30 min before skin incision if cement augmentation planned. Confirm allergies.
3

CT/Fluoroscopy Planning

CT or biplane fluoroscopy. Confirm target vertebral level using anatomic counting + scout imaging. Plan bilateral transpedicular access: pedicle width measured; cannula size selected accordingly. Map posterior vertebral body margin — use posterior cortex as landmark for ablation termination. For RFA: plan medial electrode articulation so tips are 5–10 mm apart (width of spinous process as landmark).
4

Transpedicular Access

Bilateral transpedicular approach (for thoracolumbar spine). Skin incision over pedicle. Advance 11G or 13G working cannula through pedicle into vertebral body — confirm with AP and lateral fluoroscopy. Pedicle entry at 10 o’clock position (right) and 2 o’clock position (left) on AP view. Cannula tip in anterior third of vertebral body for full coverage.
Unipedicular probe placement
CT/fluoroscopy showing unipedicular transpedicular ablation probe placement in vertebral metastasis
Unipedicular probe placement: transpedicular access with ablation probe positioned in vertebral metastasis — confirm >1 cm clearance from epidural space before initiating ablation.
5

Thermal Protection Setup (if <1 cm Epidural Clearance)

Place epidural catheter via standard technique (fluoroscopy-guided). Confirm position in epidural space at target level. Prime tubing with cold D5W (NOT saline — saline conducts electricity with RFA). Begin slow drip (not active infusion) before ablation starts. Place thermocouples in epidural space and foramina if monitoring planned.
6

Ablation

RFA (navigational bipolar): Advance electrodes coaxially through cannulas to anterior vertebral body. Ablate anterior half first (anterior-to-posterior sequence). Articulate electrode tips medially for coalescent overlapping zones. Retract electrodes to cover posterior vertebral body. Monitor thermocouple temperatures continuously.

MWA: Advance MWA antenna(e) to target. Activate per manufacturer protocol (typically 45–65W, 10–15 min). Monitor for breakthrough pain or patient response.

Cryoablation: Advance cryoprobes. Freeze 10 min → active thaw 5 min → freeze 10 min. Monitor ice ball on CT in real time. Ice ball must remain ≥5 mm from posterior wall and epidural space.
7

Intraprocedural Assessment

CT after ablation confirms ablation zone relative to tumor extent and posterior wall. Ablation zone: hyperattenuating (MWA/RFA) or hypoattenuating ice ball (cryo). Zone should encompass tumor. If posterior margin inadequate, reposition and ablate additional zone before cement.
8

Vertebral Augmentation (if Indicated)

After ablation completion (allow 30–60 min after cryoablation to avoid cement-ice interaction). Advance bone cement delivery system through working cannulas. Balloon kyphoplasty (height restoration, fracture with kyphosis) or vertebroplasty (simpler, pure cement fill) per clinical indication. Inject PMMA under continuous fluoroscopy — stop at any sign of posterior wall leak or epidural/foraminal spread. Confirm adequate filling on AP and lateral views.
9

Post-Procedure CT

CT confirms: ablation zone dimensions, cement distribution, absence of epidural cement leak, no new neural compression. Document all in procedure note.

Community Cards

Browse Card Library →
Sign in to view and create community cards
5

Troubleshooting

Inadequate ablation, probe near cord, cement issues
Access

Sclerotic Bone — Difficult Cannula Advancement

Sclerotic bone is dense and difficult to traverse. Use mallet for cannula advancement under fluoroscopy. If bone too sclerotic for standard cannula: curved or drill-assisted access systems. Confirm pedicle wall integrity with AP fluoroscopy before advancing to prevent medial breach into epidural space. RFA preferred for sclerotic lesions (effective in dense bone at lower power than MWA).

Safety Critical

Probe Near Cord / Inadequate Epidural Clearance

CT confirms probe tip or ablation zone margin <5 mm from posterior wall or epidural space. Add active thermal protection immediately: initiate cold D5W epidural drip + CO2 pneumodissection. Place thermocouple for real-time monitoring. Reduce ablation power/time and ablate in shorter pulses. If unable to safely maintain ≥5 mm margin: abort ablation and discuss with spine surgery before proceeding.

Ablation

Inadequate Ablation Zone Coverage

Post-ablation CT shows margin not encompassing tumor (especially posterior margin). Reposition electrode/antenna and ablate additional zone targeting undermargined area. For RFA: medial tip articulation achieves coalescent zones without additional access. For large tumors (>3 cm): planned overlapping zone strategy (front-to-back, then back-to-front) before starting.

Augmentation

Cement Leak on Fluoroscopy

Stop cement injection immediately. Small epidural leak: monitor closely; CT confirmation; neurology consultation for any new symptoms. Posterior wall leak with epidural cement: urgent CT; neurosurgery consultation; steroid (methylprednisolone 1 mg/kg IV) if cord compression suspected. Venous leak: usually self-limiting; monitor for pulmonary cement embolism.

Intraoperative

Nerve Root Pain During Ablation (MAC Cases)

Patient reports burning, shooting leg pain during ablation = nerve root thermal injury signal. Stop ablation immediately. Assess dermatomal distribution. Add thermal protection (epidural cooling + CO2). If symptoms persist: abort ablation at this level; obtain CT to assess proximity. Transforaminal steroid injection post-procedure may provide relief for thermal radiculitis.

6

Complications

Neurologic injury, radiation recall, spinal cord infarct, cement leak

Major Complications

  • Neurologic injury (spinal cord / nerve root) — most critical; most transient (radiculopathy, paresthesia); rare permanent deficit; epidural steroid + long-acting local anesthetic for transient cases; neurosurgery for worsening or progressive deficits
  • Spinal cord infarct — rare; vascular injury or cement compression of radicular artery; immediate MRI; high-dose steroids; ICU
  • Cement epidural leak with cord compression — emergent neurosurgery consultation; consider decompressive laminectomy
  • Ablation-related pathologic fracture — weakened bone post-ablation; prevent with concurrent augmentation in weight-bearing segments

Minor / Expected Complications

  • Post-ablation pain flare — common day 1–3; inflammatory response; dexamethasone 4 mg q8h × 3 days + scheduled NSAIDs + opioid PRN
  • Radiculopathy (transient thermal radiculitis) — foraminal spread; transforaminal steroid injection; gabapentin
  • Radiation recall with prior SBRT — ablation adjacent to SBRT field can trigger recall reaction; discuss with radiation oncology pre-procedure; steroid prophylaxis recommended
  • Infection / discitis / osteomyelitis — rare; standard procedural asepsis; cefazolin prophylaxis for augmentation
  • Cement pulmonary embolism — venous extravasation; usually asymptomatic; supportive; anticoagulation if symptomatic
  • Skin thermal injury — monopolar RFA grounding pad burns; bipolar systems minimize this risk
7

Post-Procedure Care

Neurologic checks, pain response, steroid taper, MRI follow-up

Day 0 — Immediate Recovery

  • Neurologic checks every 4 h for 24 h: motor strength (bilateral lower extremities), sensation, bowel/bladder function
  • Pain management: ketorolac + acetaminophen scheduled; opioids PRN; PCA if severe post-ablation pain
  • Dexamethasone 4 mg IV q8h × 24 h (post-ablation edema prophylaxis); then taper over 3–5 days
  • Post-ablation pain flare expected: max day 1–2; typically resolves by day 3
  • Maintain ambulation precautions if neurologic deficit noted
  • Overnight monitoring standard; consider 2-night stay for cord-adjacent procedures

Days 1–7: Post-Ablation Syndrome

  • Local pain, fever (up to 38.5°C), fatigue — expected and self-limiting
  • Continue scheduled acetaminophen; taper ketorolac by day 5
  • Pain diary documentation; VAS score at 24 h, 72 h, 1 week
  • Significant pain improvement expected by 72 h in most patients (70–80% of lytic metastasis cases)
  • Fever >38.5°C beyond 72 h: blood cultures, CT to exclude infection
  • Patient education: call if new numbness, leg weakness, bowel/bladder changes, or uncontrolled pain

Imaging Follow-up Schedule

TimepointStudyWhat to Assess
Immediately post-procedureCT (same session)Ablation zone, cement distribution, epidural space, acute neural compression
6–8 weeksMRI spine with gadoliniumLocal tumor control: non-enhancing ablation zone = adequate; enhancing nodule at margin = residual/recurrence
3 monthsMRI spineTumor control assessment; new lesions; osteoid osteoma — symptom resolution = curative
6 monthsMRI ± bone scanContinued surveillance; assess new metastatic disease; cement integration
8

Pearls & Pitfalls

Technique pearls and critical errors to avoid

Technique Pearls

Ablation + cement = superior pain control vs. cement alone for painful vertebral metastases. Ablation addresses the biologic pain generator (tumor cytokines); cement addresses mechanical pain (instability). Combining both targets both pain mechanisms.
Sclerotic metastases: RFA is preferred. Osteoblastic/sclerotic bone has high impedance limiting standard RFA; navigational bipolar RFA with lower-power generators creates predictable ablation zones in dense bone. MWA also works in sclerotic bone (less susceptible to impedance).
Osteoid osteoma of spine: RFA is curative. Target the nidus (the hypervascular central lesion on CT contrast). Ablation zone must encompass entire nidus. Symptom resolution within 24–72 h confirms successful ablation. No cement required.
Anterior-to-posterior ablation sequence for RFA in vertebral body: ablate anterior half first, then retract and ablate posterior half. This treats the full vertebral body volume and aligns with the SBRT paradigm of treating the gross tumor volume (GTV) plus the entire marrow for microscopic tumor spread.
For cryoablation: delay cement injection 30–60 min after thaw. Injecting cement into a recently frozen vertebral body risks inadequate cement polymerization due to residual cold. Wait for temperature normalization confirmed on fluoroscopy or CT.
Epidural cooling: use cold D5W only with RFA — NOT saline. Ionic saline conducts electromagnetic energy and can create a plasma field that propagates thermal injury beyond the intended zone. D5W is non-ionic and safe.

Critical Pitfalls

!
Always confirm posterior vertebral wall integrity before ablation. Intact cortex does NOT prevent thermal energy propagation from MWA or cryoablation (it does limit some RFA conduction). A compromised posterior wall = direct access for thermal injury to cord.
!
Do not ablate near cord without thermal protection in place. Epidural clearance <1 cm = mandatory thermal protection (cold saline + CO2 + thermocouple monitoring). Proceed without it only if you are willing to accept the risk of permanent cord injury.
!
Do not perform ablation alone for epidural tumor causing cord compression. Ablation cannot relieve osseous retropulsion or epidural tumor mass effect causing cord compression. Surgical decompression is required first. Ablation is an adjunct after cord decompression, not a substitute.
!
Prior SBRT is a radiation recall risk factor. Ablation energy in a previously irradiated field can trigger radiation recall reaction. Document prior radiation fields and doses; steroid prophylaxis (dexamethasone 10 mg IV pre-procedure) is recommended in previously irradiated vertebrae.
!
Do not use monopolar RFA in patients with metallic spinal implants without careful risk assessment. Current can preferentially track along metal implants causing remote thermal injury. Bipolar systems are preferred for patients with existing hardware.
9

References & Resources

Source material, modality comparison table, related procedures

Modality Comparison for Spinal Lesions

FeatureRFA (Navigational Bipolar)MWACryoablation
Ablation zone visibility on CTOccult (use thermocouples)Poorly visible (tip artifact)Excellent (ice ball = low density)
Sclerotic bone efficacyGood (low power, predictable)Good (less impedance-sensitive)Poor (ice ball occult in sclerotic)
Lytic bone efficacyExcellentExcellent (less heat-sink)Excellent
Soft tissue / paravertebral componentLimited reachModerateExcellent (sculpted zones)
Intraprocedural painModerateHighLow
Heat-sink effectYes (CSF/venous plexus)Less susceptibleN/A (cold)
Grounding pads neededNo (bipolar)NoNo
Metallic implants concernLow (bipolar)NoneNone
Cement timing after ablationImmediateImmediateDelay 30–60 min (thaw)
Best indicationLytic & sclerotic mets; myeloma; osteoid osteomaLarge lytic; osteoblastic; near vasculatureLarge soft tissue component; posterior elements; paravertebral

Primary References

  • Prologo JD, Ray CE Jr., eds. Advanced Pain Management in Interventional Radiology: A Case-Based Approach. Thieme; 2024. DOI: 10.1055/b000000387
  • Tomasian A, Jennings JW. Percutaneous vertebral augmentation. Semin Intervent Radiol. 2019;36(4):256–263.
  • Tomasian A, Gangi A, Wallace AN, Jennings JW. Percutaneous thermal ablation of spinal metastases: recent advances and review. AJR Am J Roentgenol. 2018;210(1):142–152.
  • Tran DQ, et al. Cryoneurolysis. Reg Anesth Pain Med. 2021;46(3):255–263.
  • Wallace AN, et al. The metastatic spine disease multidisciplinary working group algorithms. Oncologist. 2015;20(10):1205–1215.
  • Shah LM, Jennings JW, et al. ACR Appropriateness Criteria: management of vertebral compression fractures. J Am Coll Radiol. 2018;15(11S):S347–S364.
9

References & Resources

Primary sources · Key data · Related procedures

Key Guidelines

  • SIR Standards of Practice for Thermal Ablation
  • CIRSE Standards for Spine Ablation
  • NCCN Bone Cancer Guidelines

Primary References

  • Prologo JD et al. Percutaneous CT-guided cryoablation of the celiac plexus vs. the splanchnic nerves. J Vasc Interv Radiol. 2015;26(11):1639-1647.e1.
  • Callstrom MR et al. Painful metastases involving bone: percutaneous image-guided cryoablation — prospective trial. Radiology. 2006;241(2):572-580.
  • Gangi A et al. Interventional radiologic procedures with CT guidance in cancer pain management. Radiographics. 1996;16(6):1289-1304.